Puma Biotechnology Inc reports results for the quarter ended in September - Earnings Summary

Puma Biotechnology

03/11/2022 21:03

* Puma Biotechnology Inc  PBYI.OQ  reported a quarterly
adjusted
loss of 1 cent​​ per share for the quarter ended in September.
The mean expectation of five analysts for the quarter was for a
loss of 5 cents per share.
    * Revenue rose 23.6% to $57.10 million from a year ago;
analysts
expected $50.47 million. 
    * Puma Biotechnology Inc's reported EPS for the quarter was
a loss
of 1 cent​.
    * The mean earnings estimate of analysts had fallen by
about 250.3% in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Puma Biotechnology Inc shares had fallen by 8.9% this
quarter and lost 28.9% so far this year.
    * The company reported a quarterly loss of $400 thousand.
    * Wall Street's median 12-month price target for Puma
Biotechnology Inc is $5.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 09:03 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.05          -0.01          Beat
 Jun. 30 2022      0.01           0.21           Beat
 Mar. 31 2022      -0.17          -0.08          Beat
 Dec. 31 2021      -0.09          0.10           Beat